Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination
- PMID: 20136389
- DOI: 10.3171/2009.12.JNS09573
Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination
Abstract
Object: Stereotactic biopsy is a safe and effective technique for the diagnosis of brain tumors. The use of intraoperative neuropathological examination has been routinely advocated to increase diagnostic yield, but the procedure lengthens surgical time, may produce false-negative and -positive results, and current biopsy techniques have a very low nondiagnostic rate. Therefore, the authors questioned the need for intraoperative histological evaluation.
Methods: The authors prospectively studied all patients undergoing image-guided biopsy under the care of a single surgeon (P.L.G.) between July 2005 and October 2007. A Stryker neuronavigation system with a trajectory guide was used to plan a single trajectory, and, using a side-cutting biopsy cannula, multiple biopsy samples were taken from between 1 and 4 sites within the tumor. Tissue was inspected macroscopically by the surgeon and was only submitted for neuropathological assessment postoperatively.
Results: One hundred thirty-four biopsies were performed during the study. A positive diagnosis was established in 133 cases (99.3%). One biopsy was negative (0.7%) and postoperative imaging (performed because the tissue was macroscopically normal) demonstrated inaccurate targeting of the lesion. Significant complications were seen in 3 patients (2.2%) who all had preoperative WHO performance scores of III or IV. Two patients suffered delayed deterioration and died due to probable surgical complications--one with thalamic glioblastoma multiforme (GBM) and one with gliomatosis cerebri. One patient with GBM suffered an intracerebral hematoma that was managed conservatively. Postoperative seizures were seen in 4 patients (3%), and 2 patients (1.5%) experienced a transient neurological deficit. Histological diagnosis showed a GBM in 64 cases, Grade III glioma in 19, Grade I or II in 23, metastasis in 10, lymphoma in 13, and other disease in 4. There were 32 patients discharged to home on the same day as surgery. Compared with the authors' previous retrospective audit into 127 biopsies, this technique showed improved diagnostic yield (99.3 vs 94.5%, p = 0.032) with fewer complications (2.2 vs 4.7% [not statistically significant]).
Conclusions: This technique of image-guided biopsy has high diagnostic yield with acceptably low morbidity and may be performed as a day case. Intraoperative neuropathological examination would not have increased the diagnostic yield further in this study, and its routine use may not be necessary. In the authors' department pounds sterling 70,350 (UK)/$114,522 (US) would have been saved by not using intraoperative neuropathology in this series. Therefore, intraoperative neuropathology should no longer be routinely recommended.
Comment in
-
Biopsies and neuropathology.J Neurosurg. 2010 Aug;113(2):167-8; discussion 168-9. doi: 10.3171/2009.12.JNS091534. J Neurosurg. 2010. PMID: 20136395 No abstract available.
Similar articles
-
A prospective study of the safety and efficacy of frameless, pinless electromagnetic image-guided biopsy of cerebral lesions.Neurosurgery. 2012 Mar;70(1 Suppl Operative):29-33; discussion 33. doi: 10.1227/NEU.0b013e31822d75af. Neurosurgery. 2012. PMID: 21768917
-
Frameless robotic stereotactic biopsies: a consecutive series of 100 cases.J Neurosurg. 2015 Feb;122(2):342-52. doi: 10.3171/2014.9.JNS14107. Epub 2014 Nov 7. J Neurosurg. 2015. PMID: 25380111
-
Intraoperative magnetic resonance-guided frameless stereotactic biopsies - initial clinical experience.Neurol Neurochir Pol. 2012 Mar-Apr;46(2):157-60. doi: 10.5114/ninp.2012.28258. Neurol Neurochir Pol. 2012. PMID: 22581597
-
Diagnostic Accuracy and Field for Improvement of Frameless Stereotactic Brain Biopsy: A Focus on Nondiagnostic Cases.J Neurol Surg A Cent Eur Neurosurg. 2024 Jan;85(1):48-61. doi: 10.1055/a-1994-8033. Epub 2022 Dec 8. J Neurol Surg A Cent Eur Neurosurg. 2024. PMID: 36481998 Review.
-
Navigation-guided endoscopic biopsy for intraparenchymal brain tumor.Neurol Med Chir (Tokyo). 2011;51(10):694-700. doi: 10.2176/nmc.51.694. Neurol Med Chir (Tokyo). 2011. PMID: 22027244 Review.
Cited by
-
Intraoperative ex-vivo epifluorescent diagnostics of stereotactic brain biopsies using EndoScell scanner: diagnostic accuracy study.Neurosurg Rev. 2025 Jan 21;48(1):68. doi: 10.1007/s10143-025-03216-7. Neurosurg Rev. 2025. PMID: 39833638
-
OCT-Guided Surgery for Gliomas: Current Concept and Future Perspectives.Diagnostics (Basel). 2022 Jan 28;12(2):335. doi: 10.3390/diagnostics12020335. Diagnostics (Basel). 2022. PMID: 35204427 Free PMC article. Review.
-
Diagnostic Yield and Complication of Frameless Stereotactic Brain Biopsy.J Neurosci Rural Pract. 2019 Jan-Mar;10(1):78-84. doi: 10.4103/jnrp.jnrp_166_18. J Neurosci Rural Pract. 2019. PMID: 30765975 Free PMC article.
-
Recent technological advances in pediatric brain tumor surgery.CNS Oncol. 2017 Jan;6(1):71-82. doi: 10.2217/cns-2016-0022. Epub 2016 Dec 21. CNS Oncol. 2017. PMID: 28001090 Free PMC article. Review.
-
Neuronavigation in the surgical management of brain tumors: current and future trends.Expert Rev Med Devices. 2012 Sep;9(5):491-500. doi: 10.1586/erd.12.42. Expert Rev Med Devices. 2012. PMID: 23116076 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical